title: SYMPLICITY HTN 3: The death knell for renal denervation in hypertension?
abstract: Resistant hypertension is, by definition, a challenge to most physicians treating hypertension. Renal sympathetic denervation has shown promising early results in treating this condition. The SYMPLICITY HTN-3 is the most recent trial to report the effects of this technique on resistant hypertension. This review discusses this study and its surprising neutral results before ending with an overview of key lessons learned.
authors: National Institute of Health Research (NIHR), Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, Sydney Street, London SW3 6NP, United Kingdom.
authors: Hitesh C
authors: HC
authors: Patel
authors: National Institute of Health Research (NIHR), Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, Sydney Street, London SW3 6NP, United Kingdom.
authors: Carl
authors: C
authors: Hayward
authors: National Institute of Health Research (NIHR), Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, Sydney Street, London SW3 6NP, United Kingdom.
authors: Carlo
authors: C
authors: Di Mario
keywords: Renal denervation; resistant hypertension; trial design